Premium
Histological diagnosis of basal cell carcinoma is not associated with life expectancy in elderly Dutch people: a population‐based cohort study
Author(s) -
WaalboerSpuij R.,
Hollestein L.M.,
PollFranse L.V.,
Nijsten T.E.C.
Publication year - 2017
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15310
Subject(s) - overdiagnosis , life expectancy , medicine , cohort , asymptomatic , gerontology , prospective cohort study , harm , cohort study , basal cell carcinoma , population , basal cell , psychology , surgery , pathology , environmental health , social psychology
Determining appropriate care at the end of life is challenging and has primarily focused on life threatening diseases. Recently, Linos et al highlighted issues about the management of common, nonfatal conditions such as basal cell carcinoma (BCC) in people with limited life expectancy (LLE).(1) A prospective cohort study showed that age older than 85 years or the presence of multiple comorbidities did not influence treatment.(2) In two controversial position papers they argued that potential overdiagnosis of an asymptomatic slow growing BCC may do more harm than good, advocating a patient-centred care model. This article is protected by copyright. All rights reserved